Incidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5- fluorouracil: a meta-analysis of published trials

AIM: Capecitabine is an oral fluoropyrimidine that can effectively replace infusional 5-fluorouracil (5-FU) for treatment of colorectal, gastric and breast cancer. This study aims to analyze the incidence and the relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5-FU...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Br J Clin Pharmacol
Päätekijät: Iacovelli, Roberto, Pietrantonio, Filippo, Palazzo, Antonella, Maggi, Claudia, Ricchini, Francesca, de Braud, Filippo, Di Bartolomeo, Maria
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BlackWell Publishing Ltd 2014
Aiheet:
Reviews
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4256612/
https://ncbi.nlm.nih.gov/pubmed/24962653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12449
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia